Accutar Biotech Alternatives & Competitors
12 companies similar to Accutar Biotech — Employ AI to Revolutionize Drug Discovery
Companies similar to Accutar Biotech
Genesis Molecular AI
Unifying AI and Biotech to accelerate the discovery of new medicines
San Mateo, United States
Standigm
The workflow AI drug discovery company
Seoul, Korea South
Ascent Bio
Building the future of molecule intelligence
New Haven, United States
Track all Accutar Biotech competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Ro5
Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.
London, United Kingdom
Pharmacelera
Mine enhanced chemical space. Design superior candidates
Barcelona, Spain
Galux
Biotech leveraging AI, physics, and chemistry to design novel drugs against attractive tar...
Korea South
Antiverse
Designing functional antibodies for the most challenging targets.
Cardiff, United Kingdom
PharmCADD
PharmCADD is a company designed to accelerate drug discovery using technologies of AI and...
Busan, Korea South
AQEMIA
Scale drug discovery with quantum-inspired physics and generative AI
Paris, France
Frontier Medicines
Frontier Medicines is a biopharmaceutical company that “drugs the undruggable” to transfor...
South San Francisco, Unit...
Deargen
AI-First Pharmatech Company. We are exploring sequence-based drug discovery and developmen...
Daejeon, Korea South
About Accutar Biotech
Accutar Biotech, founded in 2015, is disrupting the drug discovery industry by employing artificial intelligence to revamp traditional methodologies. Operating from Shanghai, China and New York, NY, the company leverages its AI-driven platforms to significantly cut down on the time and expenses associated with drug dis...
AI Solutions for Drug Discovery, Drug Design and Development, AI-Powered Biological System Analysis, Data-Driven Chemical Analysis
Pharmaceutical Companies, Biotech Firms, Healthcare Researchers, Cancer Treatment Specialists
AI Drug Discovery, Computation-aided Drug Design, Flexible Mode Ligand Docking, Virtual Screening, ADME Prediction, Hybrid Drug Design Approach, Molecular Graph Convolutional Network, Deep Neural Network Docking, Lead Discovery Services, Lead Optimization, Intelligent-SAR, Biotech AI Solutions, Pharmaceutical Collaboration, Wet Lab Validation
B2B, SaaS, API
Licensing, Service Fee, Subscription
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Accutar Biotech and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Accutar Biotech on 15 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 22 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
